Swirsky, L., and L. Cook. 2008. Comparative effectiveness: Better value for the money? Wash ington, DC: Alliance for Health Reform.
Tierney, M., and B. Manns. 2008. Optimizing the use of prescription drugs in Canada through the common drug review. Canadian Medical Association Journal 178(4):432-435.
Toronto Health Economics and Technology Assessment Collaborative. 2007a. Research. http://theta.utoronto.ca/research (accessed July 1, 2008).
———. 2007b. Education. http://theta.utoronto.ca/static/education (accessed July 1, 2008).
Tu, J. V., J. Bowen, M. Chiu, D. T. Ko, P. C. Austin, Y. He, R. Hopkins, J. E. Tarride, G. Blackhouse, C. Lazzam, E. A. Cohen, and R. Goeree. 2007. Effectiveness and safety of drug-eluting stents in Ontario. New England Journal of Medicine 357(14):1393-1402.
Tunis, S. 2007. Comparative effectiveness: Basic terms and concepts. San Francisco, CA: Center for Medical Technology Policy.
Tunis, S. R., and S. D. Pearson. 2006. Coverage options for promising technologies: Medicare’s “coverage with evidence development.” Health Affairs 25(5):1218-1230.
Tunis, S. R., D. Stryer, and C. Clancy. 2003. Practical clinical trials—Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290:1624-1632.
Weissberg, J. 2007. Use of large system databases. In The Learning Healthcare System: Workshop Summary, edited by L. Olsen, D. Aisner, and J. McGinnis. Washington, DC: The National Academies Press. Pp. 46-50.
Wilensky, G. 2006. Developing a center for comparative effectiveness information. Health Affairs 25:w572-w585.
Woolf, S. 2008. The meaning of translational research and why it matters. Journal of the American Medical Association 299:211-213.
Zerhouni, E. 2007. Translational research: Moving discovery to practice. Clinical Pharmacology and Therapeutics 81:126-128.